The research behind the headlines New to GLP-1s? Start here
GLP-1 Roundup

A practical guide to the price of care.

Compare plans

SnagRx review

SnagRx advertises compounded semaglutide and tirzepatide injections in a bundled cash-pay program with clinician review and pharmacy delivery.

We may earn a commission from partner links. Our reviews cover both partners and other providers. How we are funded

Michael Hayes’s take

The decision behind the offer.

SnagRx’s flat-price message is appealing, but I would judge it by the selected billing term and clinical response pathway. I want the exact compounded preparation, dispensing pharmacy and cancellation date documented before payment. A quick intake and cheap opening figure do not resolve those questions.

See the cost and care breakdown
In this review

What you are paying for

Cash-pay compounded injections with bundled review and delivery

Medication
Compounded semaglutide or tirzepatide injections; not FDA-approved
Advertised figures
$69 or $119/month; verify selected checkout term and total
Included
Medication, supplies, doctor review and shipping described
Cancellation
72-hour billing deadline; ordinary cancellation does not refund prepaid term
Put the full year on paper

What stands out

  • Medication, supplies, review and shipping described as a bundle
  • Published portal route for refill and treatment questions
  • Formal refund terms can be reviewed before enrollment

Where I would pause

  • Compounded medication is not FDA-approved
  • 72-hour cancellation deadline in formal terms
  • Advertised fast delivery follows clinical approval and pharmacy processing

What the offer actually covers

SnagRx currently advertises compounded semaglutide and compounded tirzepatide injections. It presents medication, supplies, doctor review and shipping as a single cash-pay price. The official disclosure makes clear that the compounded products are not FDA-approved. References to established drug brands on the page do not establish that branded pens or tablets are included in this particular offer.

My first request would be a plain description of the prescribed preparation and the dispensing pharmacy. A clinician must decide whether prescribing is appropriate; paying for a program does not guarantee a prescription. The branded and compounded guide is a useful companion when comparing this offer with an insurance-based branded program.

Flat pricing still needs a full payment schedule

The home page lists $69 per month for compounded semaglutide and $119 for compounded tirzepatide, with flat pricing and no separate membership fee. It also describes month-to-month and longer subscribe-and-save arrangements. Those statements do not identify the total upfront payment, next renewal date or eligibility of the cheapest figure for every selected plan.

I would capture the complete checkout amount before comparing another provider. Write down the term purchased and the next scheduled charge, then use the first-year cost tool for that exact arrangement. The absence of an additional access fee simplifies the bill, but it does not eliminate the cost of an unused prepaid commitment. Compare financial flexibility as carefully as the medication figure.

Does this care model fit?

Review the current offer and the terms for your selected plan.

Explore SnagRxAffiliate link. We may earn a commission.

Cancellation and refunds are separate questions

The August 25, 2026 formal policy requires requests at least 72 hours before the next billing date to stop that charge. It generally treats payments as final and says multi-month purchases are not prorated on ordinary cancellation. A provider’s medical-disqualification decision allows a refund for the unused portion after applicable services are deducted.

That makes “cancel anytime” a statement about future billing, not a promise to refund everything paid. I would ask support for the selected term’s cancellation deadline and written confirmation once a request is processed. If a homepage answer seems more flexible than the formal policy, resolve the difference before paying. Your plan should still make sense without assuming a discretionary refund.

Separate an intake from the clinical decision

SnagRx describes a sequence of payment, medical intake, provider review and pharmacy fulfillment. The clinician retains prescribing discretion. I would not interpret a short qualifier or advertised review window as approval of treatment. Ask whether further records, an appointment or additional information could be needed and how you will learn the outcome.

The website identifies a clinician network and pharmacy partners, but a list does not tell you which pharmacy will fill your order. Confirm that information for the prescription actually offered. Keep administrative support separate from clinical questions: billing staff can explain a charge; the prescriber needs to address symptoms, suitability and treatment changes. The ongoing-support guide helps turn those responsibilities into a usable contact plan.

Fast shipping is not the whole refill plan

The homepage promotes quick shipping after approval and explains that refill requests run through a patient portal. Its shipping answer also describes a weekday cutoff and weekend handling. I would treat the delivery statements as published expectations, not a guarantee that every new applicant receives medication within the same number of days from payment.

Ask when to request a refill, what happens if the pharmacy needs more information and whom to contact for a delivery problem. If you are transferring care, settle the record handover first. A calendar showing review, billing and fulfillment dates is more useful than a countdown banner. For clinical concerns, keep a short timeline; our hair-loss research guide shows why a reported symptom should not be attributed to a cause without assessment.

What would change my choice

Embody is a close bundled-program comparison, with its own compounded-product disclosure and prepaid-term restrictions. LifeMD offers a different reason to enroll: branded access, insurance navigation and separate continuing care charges. Compare the models according to the problem you need solved rather than treating their opening figures as interchangeable treatment prices.

I would want SnagRx to answer three things clearly: what preparation is offered, what support continues after fulfillment and what happens financially if I stop. Clear answers make the offer reviewable. Unanswered questions should remain visible in your decision. The trial evidence overview explains why an ingredient’s clinical literature does not establish a compounded product’s equivalence or one provider’s service quality.

A different fit might be better.

Compare the reason for choosing each service, not just the name on the offer.

Based on published provider information, not personal treatment. Our review standards explain how we assess offers. A clinician must determine individual treatment suitability.

Before you go

One more option to compare.

We may earn a commission from the partner below. It is a separate provider, and eligibility and treatment decisions require its own evaluation.

Explore partner Continue to your provider